Cefamandole nafate

CAS : 42540-40-9

Ref. 3D-FC19846

Informations sur le produit

• Nom: Cefamandole nafate
• Synonymes: (6R,7R)-7-[[(2R)-2-(Formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct -2-ene-2-carboxylic acid sodium saltBergacefCedol, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-(formyloxy)-2-phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, sodium salt (1:1), (6R,7R)-, 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(formyloxy)phenylacetyl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, monosodium salt, [6R-[6α,7β(R*)]]-, Bergacef, Cedol, Cefam, Cefamandole Nafate, Cefamandole formate sodium, Cefiran, Cemado, Cemandil, Cemandil sodium salt, Cephamandole nafate, Kefadol, Kefandol, Lampomandol, Mandokef, Mandol, Mandolsan, NSC 299588, Neocefal, O-Formylcefamandole sodium, Pavecef, Sodium 7-(<span class="text-smallcaps">D</span>-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate, Sodium O-formylcefamandole, sodium (6R,7R)-7-{[(2R)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, sodium (6R,7R)-7-{[(2S)-2-(formyloxy)-2-phenylacetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, sodium (6R,7R)-7-{[(formyloxy)(phenyl)acetyl]amino}-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate, Sodium 7-(D-2-formyloxy-2-phenylacetamido)-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate

Description

Cefamandole nafate is an antimicrobial agent that is used for the treatment of infectious diseases. It has a broad spectrum of activity and is effective against Gram-positive and Gram-negative bacteria, such as staphylococci, streptococci, and pseudomonads. Cefamandole nafate has been shown to be active against tissue infection caused by E. coli in rats. The mechanism of action involves cell lysis and the formation of sodium carbonate. This reaction takes place when glucose is injected into the animal's intrauterine cavity before injecting cefamandole nafate solution. The chemical reaction between sodium carbonate and glucose produces water, carbon dioxide, sodium bicarbonate, and hydrogen ions. The hydrogen ions react with cefamandole to produce its active form, which then reacts with the bacterial cell wall by disrupting the cell membrane. Cefamandole nafate also inhibits protein synthesis by binding

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 512.5 g/mol
• Formule: C₁₉H₁₇N₆NaO₆S₂
• Degré de pureté: Min. 95%